Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes
Diabetes Technology & Therapeutics · 2023-05 · 25 (5) · 324-328
DOI: 10.1089/dia.2022.0544 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Diabetes Technology & Therapeutics, online erschienen am 15.02.2023. Verfasst von Viral N Shah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
In recent years, continuous glucose monitor (CGM) use is increasing in people without diabetes to promote healthy lifestyle. CGM metrics such as glucose management indicator (GMI), a statistical formula to estimate glycated hemoglobin (HbA1c) from sensor glucose, is commonly used to approximate HbA1c. This study was aimed to evaluate discordance between GMI and HbA1c in people without diabetes.
Methods
Children and nonpregnant adults (age ≥6 years) without diabetes (laboratory HbA1c
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Jaeb Center for Health Research, Tampa, Florida, USA.
- International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA.
ORCID-Profile: Viral N Shah, Tim Vigers, Peter Calhoun, Richard M Bergenstal
Zitieren
APA
Shah, V. N., Vigers, T., Pyle, L., Calhoun, P., & Bergenstal, R. M. (2023). Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes. Diabetes Technology & Therapeutics, 25(5), 324-328. https://doi.org/10.1089/dia.2022.0544
Vancouver
Shah VN, Vigers T, Pyle L, Calhoun P, Bergenstal RM. Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes. Diabetes Technology & Therapeutics. 2023;25(5):324-328. doi:10.1089/dia.2022.0544
BibTeX
@article{Shah2023,
author = {Shah, Viral N and Vigers, Tim and Pyle, Laura and Calhoun, Peter and Bergenstal, Richard M},
title = {Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes},
journal = {Diabetes Technology & Therapeutics},
year = {2023},
volume = {25},
number = {5},
pages = {324--328},
doi = {10.1089/dia.2022.0544}
}
EUVIMED